September 6, 2012, WINOOSKI VT, USA — BioTek Instruments proudly announces receipt of the 2012 Drug Discovery Product of the Year – Scientists' Choice Award for their Synergy™ NEO HTS Multi-Mode Microplate Reader. The award, sponsored by SelectScience, was announced September 5th at ELRIG Drug Discovery in Manchester, UK.
“This award is such a special recognition from our customers; we’re delighted to have our Synergy NEO foremost recognized among many cutting-edge drug discovery technologies,” noted Gary Barush, BioTek’s Director of Marketing & Sales. “In return, we promise to continue innovating microplate-based solutions to benefit drug discovery applications.”
BioTek’s Synergy NEO was selected among seven product finalists, as nominated by SelectScience members. NEO is specifically designed for today’s streamlined screening applications and core laboratories. Patented Hybrid Technology™ combines filter- and monochromator-based optics in the compact Synergy NEO for increased flexibility, speed and performance. Full spectrum reading in both fluorescent and absorbance modes, plus multiple parallel detectors decrease measuring time, and dedicated filter-based optics are suited for live cell assays. Additionally, an optional plate stacker with a 6-second plate exchange time increases efficiency and walk-away automation. Powerful and user-friendly Gen5™ Data Analysis Software allows custom protocol creation, data processing and export flexibility.
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. In 2011, BioTek received the North American New Product Innovation Award for Workflow Solutions in Life Sciences from Frost Sullivan. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process, provide rapid and cost-effective industrial analysis, and to enable sensitive and accurate quantification of a wide range of molecules across diverse applications.
For further information, contact:
Chere Griffin, Account Executive
Shaw & Todd Advertising and Marketing Communications